Future therapies for paediatric congenital adrenal hyperplasia

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1363, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Normal growth achievable in paediatric virilising congenital adrenal hyperplasia

By  

Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Flutamide decreases cortisol clearance in congenital adrenal hyperplasia

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Congenital Adrenal Hyperplasia: Epidemiology, Management and Practical Drug Treatment

By Merke D.  

Pediatric Drugs, Vol. 3, Iss. 8, 2001-01 ,pp. : 599-611

Adis International

Access to resources Recommend Favorite

Molecular Diagnosis of CYP21 Mutations in Congenital Adrenal Hyperplasia: Implications for Genetic Counseling

By Speiser P.W.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 101-110

Adis International

Access to resources Recommend Favorite

Therapies for adrenal insufficiency

By Andrioli Massimiliano   Pecori Giraldi Francesca   Martin Martina De   Cavagnini Francesco  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 11, 2007-11 ,pp. : 1323-1329

Informa Healthcare

Access to resources Recommend Favorite